Type 2 Diabetes in 2025: Year in Review - HCPLive Given this population’s history of limited treatment success, mifepristone is a promising new alternative to existing medications Diabetes Dialogue: Reacting to Retatrutide and TRIUMPH-4 Topline Data
What’s Next in Diabetes Care: Innovations and Insights From expanding treatment options to groundbreaking research, progress is happening With each breakthrough, we move closer to better care, improved quality of life and—one day—a cure
Use of New Diabetes Medicines | Diabetes | CDC This study showed that over 8 in 10 US adults with type 2 diabetes are eligible for new, effective diabetes medicines These medicines are not just beneficial for blood sugar management
GLP-1-based therapies for diabetes, obesity and beyond - Nature GLP-1-based therapies represent highly effective treatments for patients with type 2 diabetes and obesity This Review profiles established and emerging GLP-1-based medicines, focusing on novel